The most effective treatment is autologous bone marrow transplants with stem cell rescues.

Aggressive chemotherapy with autologous bone marrow transplant is used for metastatic medulloepitheliomas.

In autologous bone marrow transplants, the patient's own marrow is returned after the chemotherapy treatment.

There, he underwent a regimented treatment which included an autologous bone marrow transplant, which was not yet available in Malaysia.

An oncology Intensive Care Unit is the only Peninsula facility to provide stem cell and autologous bone marrow transplants.

He underwent an intensive chemotherapeutic procedure known as an autologous bone marrow transplant which involved radically high doses of chemotherapy and long stays in the hospital.

As part of an autologous bone marrow transplant the DMSO is re-infused along with the patient's own hematopoietic stem cells.

In one study of breast cancer patients [3] who underwent autologous bone marrow transplant, more PTSD-like symptoms were reported at the time of initial diagnosis.

Thousands of Lives Involved If autologous bone marrow transplants work for breast cancer, experts estimate that 25,000 women might benefit from the therapy, at a cost of about $2.5 billion.

The company's product, which is called granulocyte macrophage colony-stimulating factor, or GM-CSF, was recommended for approval for use in autologous bone marrow transplants.

The foundation of the process is an independent panel of 130 expert physicians who are asked to review questionable requests for coverage of high-dose chemotherapy with autologous bone marrow transplant.

Intensive or high-dose chemotherapy with autologous bone marrow transplant or peripheral blood stem cell rescue has not demonstrated any effectiveness in brain stem gliomas and is not recommended.

Although such autologous bone marrow transplants were first used experimentally over a decade ago as heroic treatments for hopeless cases, researchers have only recently accumulated enough data to prove definitively that they work.

Cassileth PA, Andersen J, Lazarus HM, et al.: Autologous bone marrow transplant in acute myeloid leukemia in first remission.

Little R, Wittes RE, Longo DL, et al.: Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant.

Advisory Committee for the International Autologous Bone Marrow Transplant Registry, Bone marrow autotrans plantation in man,report of an international cooperative study.

However, he recovered from the disease after undergoing a gruelling treatment involving chemotherapy, radiation therapy and an autologous bone marrow transplant at the Fred Hutchinson Cancer Research Center in Seattle.

One case of malaria has been reported in a man of African origin with sickle cell trait who was treated for B cell lymphoma with chemotherapy and an autologous bone marrow transplant.

Dr. Chabner cited one study at Duke University in which 90 percent of a small group of women with breast cancer were alive and free of the disease about three years after autologous bone marrow transplants.

Mach-Pascual S, Legare RD, Lu D, et al.: Predictive value of clonality assays in patients with non-Hodgkin's lymphoma undergoing autologous bone marrow transplant: a single institution study.

Horowitz ME, Kinsella TJ, Wexler LH, et al.: Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma.

Armand Keating, MD is completing the last cohort of patients in the Canadian trial at Princess Margaret Hospital in Toronto in lymphoma patients after autologous bone marrow transplants.

Ms. van Tilburg also said that legal battles "will not help anyone and will not move doctors and the health insurance industry any closer to having a definitive answer on whether high-dose chemotherapy and autologous bone marrow transplant therapy works."

Blue Cross recently pledged $36 million for a large-scale study of autologous bone marrow transplants - the removal and later reinsertion of bone marrow - in breast cancer patients after high doses of chemotherapy, which is toxic to blood cells.

In June 1990, Marcus was transferred to New York's Memorial Sloan-Kettering Cancer Center to undergo an autologous bone marrow transplant, but the treatment was unsuccessful and Marcus died on September 20, 1990.